Pulmatrix
IPOLexington, United States · Founded 2003 · $54.2M raised
- Headquarters
- Lexington, Massachusetts
- Employees
- 11–50
- Founded
- 2003
- Business Model
- B2B
- Website
- pulmatrix.com
- Total Funding
- $54.2M
- Last Round
- $10.0M Private EquityJun 2015
- Rounds
- 4
About
Pulmatrix is a clinical-stage biotech developing inhaled therapeutics using its iSPERSE dry powder delivery platform for respiratory and systemic diseases.
Summary
Pulmatrix is a Biotech company based in Lexington, United States, founded in 2003. It has raised $54.2M in total across 4 rounds, most recently a $10.0M Private Equity round in Jun 2015. Investors include ARCH Venture Partners and Polaris Partners.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2015
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...